Akebia Therapeutics, Inc. (AKBA)
0.8786
-0.06
(-6.51%)
USD |
NASDAQ |
Aug 28, 16:00
0.8784
0.00 (0.00%)
After-Hours: 20:00
Akebia Therapeutics 30-Day Average Daily Volume : 5.829M for Aug. 28, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| August 28, 2026 | 5.829M |
| August 27, 2026 | 5.573M |
| August 26, 2026 | 5.232M |
| August 25, 2026 | 4.822M |
| August 24, 2026 | 4.540M |
| August 21, 2026 | 4.382M |
| August 20, 2026 | 4.305M |
| August 19, 2026 | 3.999M |
| August 18, 2026 | 3.890M |
| August 17, 2026 | 4.020M |
| August 14, 2026 | 4.089M |
| August 13, 2026 | 4.159M |
| August 12, 2026 | 4.225M |
| August 11, 2026 | 4.304M |
| August 10, 2026 | 4.297M |
| August 07, 2026 | 4.400M |
| August 06, 2026 | 4.143M |
| August 05, 2026 | 3.686M |
| August 04, 2026 | 3.616M |
| August 03, 2026 | 3.696M |
| July 31, 2026 | 4.390M |
| July 30, 2026 | 4.453M |
| July 29, 2026 | 4.619M |
| July 28, 2026 | 4.738M |
| July 27, 2026 | 4.858M |
| Date | Value |
|---|---|
| July 24, 2026 | 5.352M |
| July 23, 2026 | 5.543M |
| July 22, 2026 | 5.558M |
| July 21, 2026 | 5.569M |
| July 20, 2026 | 5.571M |
| July 17, 2026 | 5.553M |
| July 16, 2026 | 5.621M |
| July 15, 2026 | 5.759M |
| July 14, 2026 | 5.794M |
| July 13, 2026 | 5.788M |
| July 10, 2026 | 5.774M |
| July 09, 2026 | 5.727M |
| July 08, 2026 | 5.675M |
| July 07, 2026 | 5.533M |
| July 06, 2026 | 5.522M |
| July 02, 2026 | 5.937M |
| July 01, 2026 | 6.314M |
| June 30, 2026 | 6.333M |
| June 29, 2026 | 6.262M |
| June 26, 2026 | 6.279M |
| June 25, 2026 | 6.029M |
| June 24, 2026 | 6.075M |
| June 23, 2026 | 6.127M |
| June 22, 2026 | 6.192M |
| June 18, 2026 | 6.414M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Emergent BioSolutions, Inc. | 1.223M |
| Exelixis, Inc. | 2.456M |
| ADMA Biologics, Inc. | 2.265M |
| Arcutis Biotherapeutics, Inc. | 1.605M |
| Relay Therapeutics, Inc. | 2.240M |